---
title: "Saba Capital Income & Opportunities Fund II terminates planned reorganization, repurchase program to continue"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/280527918.md"
description: "Saba Capital Income & Opportunities Fund II has terminated its planned reorganization, as recommended by management, due to current market conditions. The boards will reevaluate alternatives in the future. However, the previously approved share repurchase programs will continue as planned."
datetime: "2026-03-25T20:53:01.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/280527918.md)
  - [en](https://longbridge.com/en/news/280527918.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/280527918.md)
generator: "portal-rs"
---

# Saba Capital Income & Opportunities Fund II terminates planned reorganization, repurchase program to continue

**Saba Capital Income & Opportunities Fund II announced the previously approved reorganization has been terminated.**

**Key Highlights:**

-   The fund and Saba Capital Income & Opportunities Fund ended the planned reorganization based on management's recommendation.
-   Decision driven by current market conditions, with boards opting to reevaluate alternatives in the future.
-   The funds' previously approved share repurchase programs will remain in effect.

Original SEC Filing: Saba Capital Income & Opportunities Fund II \[ SABA \] - 8-K - Mar. 25, 2026

**Disclaimer**

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.

### Related Stocks

- [BRW.RT.US](https://longbridge.com/en/quote/BRW.RT.US.md)

## Related News & Research

- [Saba Capital Income & Opportunities Fund (BRW) and Saba Capital Income & Opportunities Fund II (SABA) Announce Reapproval of Merger | BRW Stock News](https://longbridge.com/en/news/296535079.md)
- [MVIR: SEK 140 million raised, three Phase II studies funded, and positive fostrox clinical results](https://longbridge.com/en/news/296445297.md)
- [Marcello Padula named CEO and continues as COO at Bleichroeder Acquisition Corp. II](https://longbridge.com/en/news/296649420.md)
- [Pelican Acquisition II files Form 3 for director Becky Fallon, reports no beneficial ownership](https://longbridge.com/en/news/296144005.md)
- [MVIR: Three phase II studies fully funded, strong clinical progress, and SEK 253.5M in cash](https://longbridge.com/en/news/296511484.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**